These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 6320035)

  • 1. Bupropion: a new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain.
    Ferris RM; Beaman OJ
    Neuropharmacology; 1983 Nov; 22(11):1257-67. PubMed ID: 6320035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily bupropion injections for 3 weeks attenuate the NE stimulation of adenylate cyclase and the number of beta-adrenergic recognition sites in rat frontal cortex.
    Gandolfi O; Barbaccia ML; Chuang DM; Costa E
    Neuropharmacology; 1983 Jul; 22(7):927-9. PubMed ID: 6312356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antidepressant drugs and central monoaminergic receptors].
    Asakura M; Tsukamoto T
    Yakubutsu Seishin Kodo; 1985 Dec; 5(4):303-19. PubMed ID: 2870595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurochemical and neuropharmacological investigations into the mechanisms of action of bupropion . HCl--a new atypical antidepressant agent.
    Ferris RM; Maxwell RA; Cooper BR; Soroko FE
    Adv Biochem Psychopharmacol; 1982; 31():277-86. PubMed ID: 6282058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prolonged administration of milnacipran, a new antidepressant, on receptors and monoamine uptake in the brain of the rat.
    Assie MB; Charveron M; Palmier C; Puozzo C; Moret C; Briley M
    Neuropharmacology; 1992 Feb; 31(2):149-55. PubMed ID: 1313158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of central serotonin S2 receptors after repeated treatment with quinupramine in rats.
    Sakamoto H; Yokoyama N; Nishimoto T; Murai K; Tatsumi H; Kohno S; Ohata K
    Jpn J Pharmacol; 1987 Apr; 43(4):369-77. PubMed ID: 3039217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of antidepressant drugs on [3H]dihydroalprenolol and [3H]imipramine ligand recognition sites in olfactory bulbectomized and sham-lesioned rats.
    Jesberger JA; Richardson JS
    Gen Pharmacol; 1986; 17(3):293-307. PubMed ID: 3013716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regionally specific neural adaptation of beta adrenergic and 5-hydroxytryptamine2 receptors after antidepressant administration in the forced swim test and after chronic antidepressant drug treatment.
    Paul IA; Duncan GE; Powell KR; Mueller RA; Hong JS; Breese GR
    J Pharmacol Exp Ther; 1988 Sep; 246(3):956-62. PubMed ID: 2843636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of serotonin2, but not of beta-adrenergic receptors during chronic treatment with amitriptyline is independent of stimulation of serotonin2 and beta-adrenergic receptors.
    Scott JA; Crews FT
    Neuropharmacology; 1986 Dec; 25(12):1301-6. PubMed ID: 3031528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of bupropion's mechanism of antidepressant activity.
    Ferris RM; Cooper BR; Maxwell RA
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):74-8. PubMed ID: 6406468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor alterations associated with serotonergic agents: an autoradiographic analysis.
    Wamsley JK; Byerley WF; McCabe RT; McConnell EJ; Dawson TM; Grosser BI
    J Clin Psychiatry; 1987 Mar; 48 Suppl():19-25. PubMed ID: 3029045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bupropion: a review of its mechanism of antidepressant activity.
    Ascher JA; Cole JO; Colin JN; Feighner JP; Ferris RM; Fibiger HC; Golden RN; Martin P; Potter WZ; Richelson E
    J Clin Psychiatry; 1995 Sep; 56(9):395-401. PubMed ID: 7665537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in alpha- and beta-receptor densities in rat brain as a result of treatment with monoamine oxidase inhibiting antidepressants.
    Cohen RM; Campbell IC; Dauphin M; Tallman JF; Murphy DL
    Neuropharmacology; 1982 Apr; 21(4):293-8. PubMed ID: 6123960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of lithium and antidepressants on monoaminergic receptors and receptor-coupled adenylate cyclase system in rat brain].
    Odagaki Y
    Hokkaido Igaku Zasshi; 1992 Mar; 67(2):247-58. PubMed ID: 1317819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of dopamine D-2, 5-HT2 receptors and beta-adrenoceptors in rat brain after prolonged treatment with a new potential antidepressant, Lu 19-005.
    Nowak G; Arnt J; Hyttel J; Svendsen O
    J Neural Transm; 1985; 64(3-4):227-38. PubMed ID: 2418155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chronic administration of antidepressant drugs on 5-HT2-mediated behavior in the rat following noradrenergic or serotonergic denervation.
    Eison AS; Yocca FD; Gianutsos G
    J Neural Transm Gen Sect; 1991; 84(1-2):19-32. PubMed ID: 1647168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical beta- and alpha 2- adrenoceptor binding, hypothalamic noradrenaline and pineal melatonin concentrations measured at different times of the day after repeated treatment of rats with imipramine, zimeldine, alaproclate and amiflamine.
    Ask AL; Fowler CJ; Hall H; Kelder D; Ross SB; Sääf J
    Acta Pharmacol Toxicol (Copenh); 1986 Jan; 58(1):16-24. PubMed ID: 3006428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of electroconvulsive therapy and antidepressant drugs on monoamine receptors in rodent brain--similarities and differences.
    Green AR; Heal DJ; Goodwin GM
    Ciba Found Symp; 1986; 123():246-67. PubMed ID: 3028726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of monoaminergic targets in the antidepressant- and anxiolytic-like effects of the synthetic alkamide riparin IV: Elucidation of further mechanisms through pharmacological, neurochemistry and computational approaches.
    Sartori DP; Oliveira NF; Valentim JT; Silva DMA; Mallman ASV; Oliveira ICM; Chaves RC; Capibaribe VC; Carvalho AMR; Rebouças MO; Macedo DS; Chaves Filho AJM; Fonteles MMF; Gutierrez SJC; Barbosa-Filho JM; Mottin M; Andrade CH; Sousa FCF
    Behav Brain Res; 2020 Apr; 383():112487. PubMed ID: 31987932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroconvulsive shock and neurotransmitter receptors: implications for mechanism of action and adverse effects of electroconvulsive therapy.
    Lerer B
    Biol Psychiatry; 1984 Mar; 19(3):361-83. PubMed ID: 6144329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.